ADL
RCUS icon

Asset Dedication LLC’s Arcus Biosciences RCUS Stock Holding History

Asset Dedication LLC’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$1.49K – 1164
2024
Q4 		$1.49K Hold
100
– – ﹤0.01% 995
2024
Q3 		$1.53K Hold
100
– – ﹤0.01% 1034
2024
Q2 		$1.52K Buy
+100
New +$1.61K ﹤0.01% 1082

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Asset Dedication LLC's RCUS Position: Q1 2025 in Review

Asset Dedication LLC sold out of Arcus Biosciences (RCUS) in Q1 2025, closing a stake of 100 shares — an estimated $1.49K sold.

Asset Dedication LLC first reported a position in RCUS in Q2 2024 and held it in 3 quarters. The position peaked at $1.53K in Q3 2024. 186 funds tracked by Wall St. Rank hold RCUS as of Q1 2025.

  • Asset Dedication LLC reported no remaining Arcus Biosciences position as of Q1 2025 after selling out during the quarter.
  • Asset Dedication LLC sold 100 Arcus Biosciences shares in Q1 2025, an estimated $1.49K.
  • Asset Dedication LLC first reported a position in Arcus Biosciences in Q2 2024 and held it in 3 quarters.
  • Asset Dedication LLC's Arcus Biosciences position peaked at $1.53K in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2025.

Based on Asset Dedication LLC's 13F filing for Q1 2025, filed 1 May 2025.